Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (12): 764-765.
Previous Articles Next Articles
ZHAO Yingying, HUANG Bei, CHAI Weibing, CHEN Xiaojiang, XIA Xiaojian, GAO Shiyi
Received:2019-01-18
Revised:2019-01-18
Online:2018-12-20
Published:2019-01-18
CLC Number:
ZHAO Yingying, HUANG Bei, CHAI Weibing, CHEN Xiaojiang, XIA Xiaojian, GAO Shiyi. One Case of Gynecomastia Induced by Amlodipine Besylate Tablets[J]. Chinese Journal of Pharmacovigilance, 2018, 15(12): 764-765.
| [1] 杨逸雨,高亚琳,李靖若.两种术式治疗男性乳房发育症的效果对比分析[J].河南医学研究,2016,25(4):633-635. [2] Lanitis S, Starren E, Read J, et al.Surgical management of Gynaecomastia: outcomes from our experience[J]. The Breast, 2008, 17(6): 596-603. [3] 辛智芳. 男性乳房发育症的处理[J].中华乳腺病杂志,2009,3(4):412-418. [4] Dickson G.Gynecomastia[J]. American family physician, 2012, 85(7):716-722. [5] 姜琼,黄俊,毛康,等.苯磺酸氨氯地平联合缬沙坦治疗高血压患者的临床观察[J].中国药房,2015,26(29):4124-4126. [6] 姚丹艳,姜玲海,朱爱军.苯磺酸氨氯地平致血管源性水肿一例[J].中国循环杂志,2016,31(1):97. [7] FDA. FDA Adverse Events Reporting System Public Dashboard[EB/OL].(2018-06-30)[2018-08-27]. https://fis.fda.gov/sense/app/d10be6bb-494e-4cd2-82e4-0135608ddc13/sheet/45beeb74-30ab-46be-8267-5756582633b4/state/analysis. [8] 李晔. 氨氯地平片致女性乳腺增生1例[J].海峡药学,2014,26(10):158. [9] Komine N, Takeda Y, Nakamata T.Amlodipine-induced gynecomastia in two patients on long-term hemodialysis therapy[J]. Clinical and experimental nephrology, 2003, 7(1): 85-86. [10] Cornes P G S, Hole A C. Amlodipine gynaecomastia[J]. The Breast, 2001, 10(6): 544-545. [11] Taylor J M, Simpson R U.Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse[J]. Cancer research, 1992, 52(9): 2413-2418. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
